Financials

  • Market Capitalization 459.13 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.57
Rapporto prezzo/fatturato
22.24

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2969
RZLT
Rezolute, Inc. - Common Stock
4.75 USD-1.66%-4.43%+9.20%-6.86%457.39 M USD
2977
SLN
Silence Therapeutics Plc - American Depository Share
9.69 USD-0.62%-3.68%+43.56%+49.77%457.70 M USD
2989
PRTA
Prothena Corporation plc - Ordinary Shares
8.59 USD-0.58%-11.08%+5.27%+37.00%449.71 M USD
3001
BNTC
Benitec Biopharma Inc. - Common Stock
12.98 USD-0.08%-3.13%+13.96%-21.85%445.92 M USD

Notizie